In vivo models of haemophilia - status on current knowledge of clinical phenotypes and therapeutic interventions.
Animal models have contributed immensely to the understanding of and the improvement in treatment of haemophilia A and B. First, establishment of haemophilic dog colonies provided an invaluable opportunity to investigate the diseases and later, the advances in gene technologies resulting in small haemophilic animal models were a milestone in the preclinical research making it possible to address some of the many unanswered questions. This review provides an overview of animal models used in the study of haemophilia as well as a short overview of the contributions resulting from studies in these models.
Øvlisen
K
K
Novo Nordisk A/S, Måløv, Denmark. saq@novonordisk.com
Kristensen
A T
AT
Tranholm
M
M
D000818:Animals; D001947:Breeding; D004195:Disease Models, Animal; D004285:Dogs; D005818:Genetic Engineering; D006467:Hemophilia A / Q000188:drug therapy / Q000235:genetics; D006490:Hemostatics / Q000627:therapeutic use; D051379:Mice; D008822:Mice, Transgenic; D023421:Models, Animal; D011817:Rabbits
D006490:Hemostatics